Codon Usage and Adenovirus Fitness: Implications for Vaccine Development

Vaccination is the most effective method to date to prevent viral diseases. It intends to mimic a naturally occurring infection while avoiding the disease, exposing our bodies to viral antigens to trigger an immune response that will protect us from future infections. Among different strategies for...

Full description

Bibliographic Details
Main Authors: Judit Giménez-Roig, Estela Núñez-Manchón, Ramon Alemany, Eneko Villanueva, Cristina Fillat
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2021.633946/full
_version_ 1818916391547305984
author Judit Giménez-Roig
Estela Núñez-Manchón
Ramon Alemany
Eneko Villanueva
Cristina Fillat
Cristina Fillat
Cristina Fillat
author_facet Judit Giménez-Roig
Estela Núñez-Manchón
Ramon Alemany
Eneko Villanueva
Cristina Fillat
Cristina Fillat
Cristina Fillat
author_sort Judit Giménez-Roig
collection DOAJ
description Vaccination is the most effective method to date to prevent viral diseases. It intends to mimic a naturally occurring infection while avoiding the disease, exposing our bodies to viral antigens to trigger an immune response that will protect us from future infections. Among different strategies for vaccine development, recombinant vaccines are one of the most efficient ones. Recombinant vaccines use safe viral vectors as vehicles and incorporate a transgenic antigen of the pathogen against which we intend to generate an immune response. These vaccines can be based on replication-deficient viruses or replication-competent viruses. While the most effective strategy involves replication-competent viruses, they must be attenuated to prevent any health hazard while guaranteeing a strong humoral and cellular immune response. Several attenuation strategies for adenoviral-based vaccine development have been contemplated over time. In this paper, we will review them and discuss novel approaches based on the principle that protein synthesis from individual genes can be modulated by codon usage bias manipulation. We will summarize vaccine approaches that consider recoding of viral proteins to produce adenoviral attenuation and recoding of the transgene antigens for both viral attenuation and efficient viral epitope expression.
first_indexed 2024-12-20T00:17:26Z
format Article
id doaj.art-eafe543a960a4808b6765f4110b58474
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-20T00:17:26Z
publishDate 2021-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-eafe543a960a4808b6765f4110b584742022-12-21T20:00:17ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2021-02-011210.3389/fmicb.2021.633946633946Codon Usage and Adenovirus Fitness: Implications for Vaccine DevelopmentJudit Giménez-Roig0Estela Núñez-Manchón1Ramon Alemany2Eneko Villanueva3Cristina Fillat4Cristina Fillat5Cristina Fillat6Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainInstitut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainProcure Program, Institut Català d’Oncologia- Oncobell Program, IDIBELL, L’Hospitalet de Llobregat, Barcelona, SpainCambridge Centre for Proteomics, Department of Biochemistry, University of Cambridge, Cambridge, United KingdomInstitut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, SpainCentro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, SpainFacultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, SpainVaccination is the most effective method to date to prevent viral diseases. It intends to mimic a naturally occurring infection while avoiding the disease, exposing our bodies to viral antigens to trigger an immune response that will protect us from future infections. Among different strategies for vaccine development, recombinant vaccines are one of the most efficient ones. Recombinant vaccines use safe viral vectors as vehicles and incorporate a transgenic antigen of the pathogen against which we intend to generate an immune response. These vaccines can be based on replication-deficient viruses or replication-competent viruses. While the most effective strategy involves replication-competent viruses, they must be attenuated to prevent any health hazard while guaranteeing a strong humoral and cellular immune response. Several attenuation strategies for adenoviral-based vaccine development have been contemplated over time. In this paper, we will review them and discuss novel approaches based on the principle that protein synthesis from individual genes can be modulated by codon usage bias manipulation. We will summarize vaccine approaches that consider recoding of viral proteins to produce adenoviral attenuation and recoding of the transgene antigens for both viral attenuation and efficient viral epitope expression.https://www.frontiersin.org/articles/10.3389/fmicb.2021.633946/fullcodon optimizationviral attenuationlive-attenuated vaccinesadenovirus-based vaccinescodon usage bias
spellingShingle Judit Giménez-Roig
Estela Núñez-Manchón
Ramon Alemany
Eneko Villanueva
Cristina Fillat
Cristina Fillat
Cristina Fillat
Codon Usage and Adenovirus Fitness: Implications for Vaccine Development
Frontiers in Microbiology
codon optimization
viral attenuation
live-attenuated vaccines
adenovirus-based vaccines
codon usage bias
title Codon Usage and Adenovirus Fitness: Implications for Vaccine Development
title_full Codon Usage and Adenovirus Fitness: Implications for Vaccine Development
title_fullStr Codon Usage and Adenovirus Fitness: Implications for Vaccine Development
title_full_unstemmed Codon Usage and Adenovirus Fitness: Implications for Vaccine Development
title_short Codon Usage and Adenovirus Fitness: Implications for Vaccine Development
title_sort codon usage and adenovirus fitness implications for vaccine development
topic codon optimization
viral attenuation
live-attenuated vaccines
adenovirus-based vaccines
codon usage bias
url https://www.frontiersin.org/articles/10.3389/fmicb.2021.633946/full
work_keys_str_mv AT juditgimenezroig codonusageandadenovirusfitnessimplicationsforvaccinedevelopment
AT estelanunezmanchon codonusageandadenovirusfitnessimplicationsforvaccinedevelopment
AT ramonalemany codonusageandadenovirusfitnessimplicationsforvaccinedevelopment
AT enekovillanueva codonusageandadenovirusfitnessimplicationsforvaccinedevelopment
AT cristinafillat codonusageandadenovirusfitnessimplicationsforvaccinedevelopment
AT cristinafillat codonusageandadenovirusfitnessimplicationsforvaccinedevelopment
AT cristinafillat codonusageandadenovirusfitnessimplicationsforvaccinedevelopment